Back

Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model

Ranjan, R.; Ravichandra, A.; Putze, P.; Chernysheva, A.; Wirth, J.; Lucarelli, D.; Ng, W. Y.; Pavlovska, O.; Sibanda, K. S.; Leipe, E.; Schicktanz, F.; Bärthel, S.; Schlitter, A. M.; Ollinger, R.; Ringelhan, M.; Maurer, C.; Mogler, C.; Nawroth, R.; Schmid, R. M.; Schneider, G.; Rad, R.; Steiger, K.; Saur, D.; Reichert, M.

2026-07-09 cancer biology
10.64898/2026.06.26.734719 bioRxiv
Show abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense, desmoplastic microenvironment that drives disease progression, yet conventional models fail to capture this complex tumor-stroma coevolution. Here, we utilize the chick chorioallantoic membrane (CAM) platform to investigate tumor-stroma interactions using murine PDAC cell lines and patient-derived organoids (PDOs). Integrating single-cell RNA sequencing and spatial transcriptomics, we show that the CAM microenvironment supports the emergence of complex tumor ecosystems while preserving patient-specific characteristics. Within five days, in ovo tumors faithfully recapitulated the structural and molecular features of parental tumors. Histological analysis revealed the rapid recruitment and spatial organization of heterogeneous host cancer-associated fibroblast (CAF) populations, showcasing distinct myofibroblastic and inflammatory stromal states. Crucially, the model preserved intrinsic tumor heterogeneity and permitted functional interrogation of subtype-specific extracellular matrix remodeling and metastatic dissemination. Together, our findings demonstrate that the CAM provides a highly permissive niche for tumor-stroma coevolution. As a rapid, scalable, and biologically relevant platform, this in ovo model offers a powerful approach for studying stromal composition, metastatic progression, and patient-specific tumor biology in pancreatic cancer.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
JCI Insight
277 papers in training set
Top 0.1%
15.1%
2
Cancer Research
130 papers in training set
Top 0.1%
11.1%
3
Nature Communications
5641 papers in training set
Top 23%
6.8%
4
Cancer Discovery
66 papers in training set
Top 0.4%
5.5%
5
Cell Reports
1498 papers in training set
Top 8%
4.9%
6
Developmental Cell
196 papers in training set
Top 1.0%
4.1%
7
Science Advances
1243 papers in training set
Top 9%
3.4%
50% of probability mass above
8
Advanced Science
286 papers in training set
Top 3%
2.7%
9
The Journal of Pathology
26 papers in training set
Top 0.2%
2.7%
10
Scientific Reports
3612 papers in training set
Top 47%
2.1%
11
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 26%
1.9%
12
Cancer Cell
42 papers in training set
Top 0.7%
1.7%
13
eLife
5828 papers in training set
Top 50%
1.7%
14
Communications Biology
993 papers in training set
Top 15%
1.7%
15
Genome Medicine
183 papers in training set
Top 3%
1.7%
16
Cellular and Molecular Gastroenterology and Hepatology
46 papers in training set
Top 0.6%
1.5%
17
Journal of Clinical Investigation
179 papers in training set
Top 4%
1.1%
18
Molecular Cancer
16 papers in training set
Top 0.2%
1.1%
19
Cell Communication and Signaling
51 papers in training set
Top 0.9%
1.1%
20
EMBO Molecular Medicine
95 papers in training set
Top 2%
1.0%
21
Cell Reports Medicine
153 papers in training set
Top 4%
1.0%
22
Cell Reports Methods
165 papers in training set
Top 4%
0.8%
23
iScience
1154 papers in training set
Top 34%
0.8%
24
Cancer Research Communications
51 papers in training set
Top 2%
0.8%
25
Cell Stem Cell
62 papers in training set
Top 2%
0.8%
26
Molecular Cancer Research
49 papers in training set
Top 1%
0.6%
27
The EMBO Journal
309 papers in training set
Top 7%
0.6%
28
Nature
645 papers in training set
Top 11%
0.6%
29
Nature Materials
28 papers in training set
Top 0.7%
0.6%